Effect of escalating doses of recombinant human granulocyte colony—stimulating factor (filgrastim) on circulating neutrophils in healthy subjects
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference23 articles.
1. Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony—stimulating factor;Nicola;J Biol Chem,1983
2. Purification and biochemical characterization of human pluripotent hematopoietic colony—stimulating factor;Welte;Proc Nat Acad Sci USA,1985
3. Recombinant pluripotent human granulocyte colony stimulating factor: Effects on normal and leukemic myeloid cells;Souza;Science,1986
4. Biological activities of a human pluripotent hemopoietic colony stimulating factor on normal and leukemic cells;Platzer;J Exp Med,1985
5. Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony—stimulating factor with optimization of dose and duration of therapy;Morstyn;J Clin Oncol,1989
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetic and Pharmacodynamic Characteristics of Tripegfilgrastim, a Pegylated G‐CSF, in Pediatric Patients with Solid Tumors;Clinical Pharmacology & Therapeutics;2021-10-27
2. Dynamic trade‐offs in granulocyte colony‐stimulating factor ( G‐CSF ) administration during chemotherapy;System Dynamics Review;2020-10
3. Biosimilarity Assessment of 2 Filgrastim Therapeutics in Healthy Volunteers;Clinical Pharmacology in Drug Development;2020-08-21
4. Pharmacokinetics and Pharmacodynamics of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta in Healthy Subjects: A Randomized, Double-blind Trial;Clinical Therapeutics;2020-08
5. A physiological model of granulopoiesis to predict clinical drug induced neutropenia from in vitro bone marrow studies: with application to a cell cycle inhibitor;Journal of Pharmacokinetics and Pharmacodynamics;2020-03-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3